Translational Genomics Research Institute

Short description: Research institute

A non-profit genomics research institute.

This article contains content that is written like an advertisement. Please help improve it by removing promotional content and inappropriate external links, and by adding encyclopedic content written from a neutral point of view. (March 2020) (Learn how and when to remove this template message)

|

[ ⚑ ]  33°27′10.68″N 112°4′1.83″W﻿ / ﻿33.4529667°N 112.067175°W﻿ / 33.4529667; -112.067175

Translational Genomics Research InstituteType| Research Institute

|

Industry| Genomics
Founded| July 2002, Phoenix, Arizona, United States
Headquarters| Phoenix, Arizona, United States

Key people

| Jeffrey Trent
Revenue|

* $51.7 million (2007)[1]
* $18.3 million (2003)[1]

Number of employees

| 258 (2008)[1]
Website| www.tgen.org

The Translational Genomics Research Institute at night

The Translational Genomics Research Institute (TGen)

is a non-profit genomics research institute based in Phoenix, Arizona, United States.

## Contents

* 1 History and activities
* 2 TGen Administration
* 3 References
* 4 External links

## History and activities

TGen was established in July 2002 by Jeffrey Trent in Phoenix, Arizona, with an initial investment of US$100 million from Arizona public and private-sector investors.[1]

The field of translational genomics research searches for ways to apply results from the Human Genome Project to the development of improved diagnostics, prognostics, and therapies for cancer, neurological disorders, diabetes and other complex diseases.

The mission of TGen is to make and translate genomic discoveries into advances in human health.[2] TGen has contributed to the growth of scientific research and biotechnology in Arizona. The institute has been involved in collaborations and studies, such as the research on chronic traumatic encephalopathy (CTE) in former NFL players in partnership with Exosome Sciences.

## TGen Administration

* Jeffrey M. Trent, Ph.D., President & Scientific Director[1]
* Sunil Sharma, MD FACP, Deputy Director
* Michael Bassoff, President, TGen Foundation
* Daniel Von Hoff, M.D., F.A.C.P., Executive Vice President, Physician-in-Chief[2]
* Tess Burleson, MBA, CPA, Chief Operating Officer and President, TGen Accelerators
* Chuck Coleson, Chief Financial Officer
* Galen Perry, Vice President, Marketing and Communications
* Brady Young, Vice President, Human Resources
* Kendall Van Keuren-Jensen, co-Director[3]

## References

1. ↑ 1.0 1.1 1.2 1.3 1.4 Alltucker, Ken (16 April 2008). "5-year-old TGen fights for funding". The Arizona Republic. http://www.azcentral.com/business/articles/2008/04/16/20080416biz-tgenfund0416.html.
2. ↑ 2.0 2.1 Alltucker, Ken (16 April 2008). "Cancer-drug trials show promise". The Arizona Republic. http://www.azcentral.com/business/articles/2008/04/16/20080416biz-tgenfund0416side.html.
3. ↑ "Exosome Sciences, TGen to Launch Study of CTE in Former NFL Players". CellOMICs. 26 March 2018. https://www.clinicalomics.com/articles/exosome-diagnostics-tgen-to-launch-study-of-cte-in-former-nfl-players/1551.

## External links

* Official website

0.00

(0 votes)

Original source: https://en.wikipedia.org/wiki/Translational Genomics Research Institute. Read more

|

Retrieved from "https://handwiki.org/wiki/index.php?title=Organization:Translational_Genomics_Research_Institute&oldid=3396953"